Evidence map›Paper›PMID 37449878›Full record

ArticleAnnals of medicine2023

Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents.

Kimberly H Nguyen, Ariella Levisohn, Cheyenne McChesney, Lavanya Vasudevan, Robert A Bednarczyk, Laura Corlin

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kimberly H NguyenDepartment of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, USA.ORCID 0000-0002-3558-6983
Ariella LevisohnDepartment of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Cheyenne McChesneyDepartment of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Lavanya VasudevanHubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Robert A BednarczykHubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Laura CorlinDepartment of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Tufts University · USEmory University · US

Funding

TweenVax: A comprehensive practice-, provider-, and parent/patient-level intervention to improve adolescent HPV vaccination.R37CA234119 · NCI · EMORY UNIVERSITY · PI BEDNARCZYK, ROBERT A. · 2019 to 2025
$3.7M
NCI NIH HHS R37 CA234119
6 · The paper itself

Abstract

introductionDespite recommendations for COVID-19 primary series completion and booster doses for children and adolescents, coverage has been less than optimal, particularly in some subpopulations. This study explored disparities in childhood/adolescent COVID-19 vaccination, parental intent to vaccinate their children and adolescents, and reasons for non-vaccination in the US.

methodsUsing the U.S. Census Bureau's Household Pulse Survey (HPS), we analyzed households with children aged <18 years using data collected from September 14 to November 14, 2022 (

resultsOverall, approximately half (50.1%) of children aged < 18 years were vaccinated against COVID-19 (≥1 dose). Completed primary series vaccination was 44.2% among all children aged <18 years. By age group, completed primary series was 13.2% among children <5 years, 43.9% among children 5-11 years, and 63.3% among adolescents 12-17 years. Booster vaccination among those who completed the primary series was 39.1% among children 5-11 years and 55.3% among adolescents 12-17 years. Vaccination coverage differed by race/ethnicity, educational attainment, household income, region, parental COVID-19 vaccination status, prior COVID-19 diagnosis, child's age group, and parental age group. Parental reluctance was highest for children aged <5 years (46.8%). Main reasons for non-vaccination among reluctant parents were concerns about side effects (53.3%), lack of trust in COVID-19 vaccines (48.7%), and the belief that children do not need a COVID-19 vaccine (38.8%).

conclusionDisparities in COVID-19 vaccination coverage among children and adolescents continue to exist. Further efforts are needed to increase COVID-19 primary series and booster vaccination and parental confidence in vaccines.

Indexed as

COVID-19COVID-19 VaccinesAdolescentChildCOVID-19 TestingHumansIntentionParentsVaccinationVaccination CoverageCOVID-19 Vaccinesadolescentsbooster vaccinationchildrenCOVID-19 vaccinationdisparitiesnationally representativeparentsprimary seriesUnited Statesvaccine confidencevaccine hesitancy

Identifiers

PMID37449878
PMCPMC10351440
OpenAlexW4384338970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.